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ABSTRACT
The risk of terrorism with nuclear or radiologic weapons is considered to be high over the coming decade.
Ionizing radiation can cause a spectrum of hematologic toxicities, from mild myelosuppression to myeloabla-
tion and death. However, the potential regenerative capacity of human hematopoietic stem cells (HSCs) after
radiation injury has not been well characterized. In this study, we sought to characterize the effects of ionizing
radiation on human HSCs and to determine whether signals from vascular endothelial cells could promote the
repair of irradiated HSCs. Exposure of human bone marrow CD34 cells to 400 cGy caused a precipitous
decline in hematopoietic progenitor cell content and primitive cells capable of repopulating nonobese diabetic/
severe combined immunodeficient mice (SCID-repopulating cells), which was not retrievable via treatment
with cytokines. Conversely, culture of 400 cGy–irradiated bone marrow CD34 cells with endothelial cells
under noncontact conditions supported the differential recovery of both viable progenitor cells and primitive
SCID-repopulating cells. These data illustrate that vascular endothelial cells produce soluble factors that
promote the repair and functional recovery of HSCs after radiation injury and suggest that novel factors with
radiotherapeutic potential can be identified within this milieu.
© 2006 American Society for Blood and Marrow Transplantation
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Increasing levels of exposure to ionizing radiation
an cause a spectrum of damage to the skin and the
ematopoietic, gastrointestinal, pulmonary, and cen-
ral nervous systems [1-4]. The hematopoietic and
mmune systems are among the most sensitive tissues
o the adverse effects of ionizing radiation: lympho-
yte decline and thrombocytopenia are reported after
s low as 50 cGy of exposure [4]. After 400 cGy of
xposure, more severe myelosuppression occurs, and
he mortality risk is estimated to be 50% in the ab-
ence of medical intervention [4]. At doses 400 cGy,
one marrow (BM) failure and death can occur despite
aximal supportive care with transfusion support and
ntibiotics [2-4].
Experimental studies have demonstrated that low-
ose ionizing radiation induces cellular apoptosis via
ctivation of Fas ligand–mediated pathways [5,6], b
30hereas higher-dose radiation induces double-stranded
NA damage, which causes necrotic cell death in pro-
iferating cells [7]. It is interesting to note that the
dministration of interleukin (IL)–1 or stem cell factor
SCF) before or at the time of high-dose radiation
xposure protects mice from radiation lethality, thus
uggesting that induction of stem/progenitor cells into
ate S phase of the cell cycle is radioprotective [8,9].
lternately, administration of tumor necrosis factor ,
hich induces production of free-radical scavengers, is
lso radioprotective [10], although its efﬁcacy is evi-
ent primarily after low-dose radiation exposure [11].
dministration of megakaryocyte growth and develop-
ent factor (MGDF), a ligand for Mpl [12], at the time
f high-dose irradiation is also 100% radioprotective in
ice and has been shown to inhibit the actions of p53
o prevent radiation-induced apoptosis [12]. The com-
ined administration of SCF, fms-like tyrosine kinase
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Endothelial Cells Rescue Irradiated Stem Cells
B(Flt-3) ligand, thrombopoietin (TPO), IL-3, and
tromal cell derived factor 1 (SDF-1) to B6D2F1 mice
ithin 2 hours after 800 cGy has also been shown to
upport the survival of 87.5% of mice, compared with
.3% in controls [13]. However, in the event of a
uclear blast or a nuclear power plant accident, the
dministration of cytokines to victims within 2 hours
f exposure will be difﬁcult. Moreover, experimental
tudies have yielded conﬂicting results with regard
o the potential beneﬁts of cytokine administration
hen they are administered more than 2 to 4 hours
fter high-dose radiation exposure [9,14-18]. For
xample, Macvittie et al. [14] demonstrated that the
dministration of 10 g/kg/d of granulocyte colo-
y-stimulating factor plus supportive care begin-
ing at 20 hours after 500 cGy of total body irra-
iation was associated with 75% survival of dogs,
ompared with 0% survival in untreated animals.
onversely, Zsebo et al. [9] demonstrated that ad-
inistration of 100 g/kg SCF beginning 4 hours
fter a lethal dose (1150 cGy) of total body irradia-
ion in mice provided no radioprotection in any
nimals, and Neelis et al. [16] showed that the
adioprotective effects of thrombopoietin were dra-
atically reduced between 2 and 24 hours after 600
Gy of exposure in mice. Taken together, these data
ndicate that additional therapies capable of accel-
rating hematopoietic reconstitution several hours
o days after radiation-induced aplasia should be
xplored.
We examined the capacity of primary vascular
ndothelial cells (ECs) to support the self-renewal and
xpansion of murine, primate, and human hematopoi-
tic stem cells (HSCs) [19-21]. In addition to the
ontribution of osteoblasts in supporting HSCs within
he BM niche [22,23], the potential role of ECs in the
M vascular niche has recently been suggested [24].
e have observed that primary human brain ECs
HUBECs) support, in noncontact culture, a 1 to 2 log
xpansion of human BM and cord blood (CB) severe
ombined immunodeﬁcient (SCID)-repopulating cells
SRCs) [25,26]. We also have observed that HSCs har-
ested from the BM of lethally irradiated C57BL/6 mice
ould be functionally rescued via coculture with brain
Cs [19]. In this study, we examined whether human
SCs could be rescued from the deleterious effects of
onizing radiation via coculture with primary HU-
ECs. We found that soluble factors elaborated by
UBECs support the recovery and expansion of irra-
iated human BM HSCs, whereas treatment with cy-
okines alone is ineffective.
ETHODS
UBEC Cultures
HUBECs (passage 10) were developed in pri-
ary culture from explanted cortical brain vessel seg- H
B&MTents (obtained via autopsy specimens from the Uni-
ersity of California-Los Angeles Department of
europathology) as previously described [21]. These
ells highly express human von Willebrand factor,
hus indicating an endothelial phenotype (data not
hown). Brieﬂy, gelatin-coated 6-well plates (Costar,
ambridge, MA) were seeded with 1  105 HUBECs
n complete EC medium containing Medium 199 (In-
itrogen, Carlsbad, CA), 10% heat-inactivated fetal bo-
ine serum (FBS; Hyclone, Logan, UT), 0.3 mg/mL
-glutamine, 100 U/mL penicillin, 100 g/mL strepto-
ycin (1% penicillin/streptomycin), 60 mg/L EC
rowth supplement, and 4.5 U/mL heparin (Sigma, St.
ouis, MO). HUBECs were cultured for 48 hours to
90% conﬂuence in a 37°C, 5% carbon dioxide atmo-
phere before the establishment of CD34 cell cocul-
ures.
rradiation of Human CD34 Cells and
n Vitro Coculture
Cryopreserved human BM CD34 (Cambrex,
aithersburg, MD) or CB CD34 cells (AllCells,
erkeley, CA) were thawed, washed once, and resus-
ended at 1  106/mL in Iscove modiﬁed Dulbecco
edium (IMDM; Invitrogen) containing 10% FBS
nd 1% penicillin/streptomycin. CD34 cells (95%
urity) were then exposed to 400 cGy in vitro in
olystyrene conical tubes (Becton Dickinson, San
ose, CA) by using a cesium 137 radiation source.
ells were maintained on ice and placed into culture 2
ours after irradiation. A dose of 400 cGy was used
ecause this is a representative level of exposure that
as been estimated to occur after nuclear power plant
ccidents [27].
Cultures were established with 1 to 2  105 irra-
iated BM or CB CD34cells in 6-well plates with
edia containing IMDM, 10% FBS, 1% penicillin/
treptomycin, 20 ng/mL thrombopoietin, 120 ng/mL
CF, and 50 ng/mL fms-like Flt-3 ligand (TSF; R&D
ystems, Minneapolis, MN). For noncontact HUBEC
ocultures, irradiated BM or CB CD34 cells were
laced into 0.4-m polystyrene transwell inserts
Costar). Cultures were maintained in a 37°C, 5%
arbon dioxide atmosphere for 10 days, with media
upplementation (2 mL per well) at day 7. At day 10,
onadherent cells were collected from the culture by
igorous ﬂushing with warm IMDM containing 10%
BS and 1% penicillin/streptomycin.
n Vitro Hematopoietic Progenitor Cell Assays
BM CD34 and CB CD34 cells that were irra-
iated in vitro with 400 cGy were analyzed for immu-
ophenotype at 6 hours after irradiation. Day 0 non-
rradiated cells were analyzed as controls. Irradiated
ell subsets were also placed in culture with TSF or
UBECs under contact and noncontact conditions
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5pproximately 4 hours after irradiation. Day 10 cul-
ured progeny were collected and washed with phos-
hate-buffered saline (Invitrogen) and resuspended in
MDM with 10% FBS and 1% penicillin/streptomy-
in. The total viable cell count was determined by
emacytometer count with trypan blue dye exclusion.
or phenotype analysis, cells were stained with anti-
D34 ﬂuorescein isothiocyanate and anti-CD38 phy-
oerythrin or the appropriate immunoglobulin G iso-
ype control antibodies (Becton Dickinson) for 30
inutes on ice. For apoptosis analysis, cells were
tained with anti-annexin (Becton Dickinson) V ﬂuo-
escein isothiocyanate, anti-CD38 phycoerythrin, and
nti-CD34 allophycocyanin for 30 minutes on ice.
ells were washed twice and stained with 7-amino-
ctinomycin D (7-AAD; Becton Dickinson) for 10
inutes on ice before analysis. Sample acquisition
as conducted on a FACScalibur ﬂow cytometer
Becton Dickinson). Statistical comparisons be-
ween groups were performed by using the t test.
Colony-forming assays were established in Metho-
ult GF H4434 complete methylcellulose medium
Stem Cell Technologies, Vancouver, BC, Canada)
ith 1  103 cells per dish in 35-mm gridded petri
ishes (Nunc, Rochester, NY), according to the
anufacturer’s recommended protocol. After 14
ays, triplicate cultures were scored for burst-form-
ng units-erythroid (BFU-E), colony-forming units-
ranulocyte monocyte (CFU-GM), and colony-
orming unit-mix (CFU-Mix) colony (50 cells)
ormation.
onobese Diabetic/SCID Repopulation Assays
Six- to 8-week-old nonobese diabetic/SCID (NOD/
CID) mice [28] underwent transplantation with day 0
00 cGy–irradiated BM CD34 cells (0.75-1.5  106)
r their cultured progeny. A subset of mice was also
njected with an identical dose of normal, day 0 non-
rradiated BM CD34 cells as a positive control.
OD/SCID mice received transplants via tail vein
njection after receiving 300 cGy of total body irradi-
tion on an X-Rad 320 irradiation system (AGFA
DT Inc., Lewistown, PA) at a dose rate of 100
Gy/min 4 hours before transplantation, as previously
escribed [26]. Eight weeks after transplantation, mice
ere killed, and marrow was collected from bilateral
emurs by ﬂushing with cold Dulbecco’s phosphate
uffered saline with 10% FBS. Red cells were lysed by
sing red blood cell lysing buffer (Sigma) and washed
wice, and ﬂow cytometric analysis was performed to
etermine human hematopoietic engraftment by us-
ng monoclonal antibodies against human leukocyte
ifferentiation antigens to identify engrafted human
eukocytes and discriminate their hematopoietic lin-
ages [21,29]. Mice were scored as positively engrafted
f the BM displayed 0.1% human CD45 cells via H
32igh-resolution ﬂow cytometry analysis, consistent
ith previously published criteria for human cell re-
opulation in NOD/SCID mice [30,31].
ESULTS
ontact and Noncontact Culture with HUBECs
ncreases the Recovery of Irradiated
ematopoietic Progenitors
The combination of thrombopoietin, SCF, and
lt-3 ligand (TSF) has been shown to optimize the in
itro maintenance of CB SRCs [32,33], and our
roup has shown that these same cytokines, when
ombined with HUBECs, maximize the ex vivo ex-
ansion of puriﬁed BM CD34CD38 SRCs [26].
herefore, we chose to compare the capacity for
SF alone versus HUBEC plus TSF to support the
ecovery of BM and CB CD34 cells after irradia-
ion with 400 cGy.
Culture of 400 cGy–irradiated BM CD34 cells
ith TSF alone supported a 2.8-fold increase in total
iable cells compared with day 0 cells; however, a
igniﬁcant decrement in the CD34CD38 subset was
bserved by day 10 (Figure 1A and B). Conversely,
UBEC contact cultures supported an 11.3-fold in-
rease in total cells at day 10 and were associated with a
igniﬁcant increase in the percentage of CD34CD38
ells in culture (mean, 18.2%) compared with TSF alone
mean, 0.5%; P .005). This translated into a 29.4-fold
ncrease in CD34CD38 cells in HUBEC contact cul-
ures compared with input, as compared with a 4.9-fold
ecrease in CD34CD38 cells with cytokines alone.
ulture of irradiated BM CD34 cells with HUBECs
nder noncontact conditions supported a 5.8-fold ex-
ansion of total cells and a 4.8-fold increase in the
D34 CD38 subset compared with day 0 cells (Fig-
re 1A and B). Although this was signiﬁcantly less than
he recovery observed in HUBEC contact cultures, the
ecovery of total viable cells and CD34CD38 cells in
oncontact HUBEC cultures was signiﬁcantly in-
reased compared with TSF cultures alone (P  .01
nd P  .01, respectively).
Irradiation of human CB CD34 cells yielded
imilar results as compared with BM CD34 cells.
fter a 10-day culture with TSF alone, a 9.2-fold
xpansion of total cells was observed, but a 3.9-fold
ecline in CD34CD38 cells occurred by day 10
Figure 1C and D). In contrast, HUBEC contact cul-
ures supported a 29.5-fold increase in total cells and
28.6-fold increase in CD34CD38 cells compared
ith input. Noncontact HUBEC cultures supported a
7.7-fold increase in total cells and a 3.9-fold increase
n CD34CD38 cells (Figure 1C and D). The re-
overy and expansion of total viable cells and
D34CD38 cells was signiﬁcantly higher in both
UBEC contact and noncontact cultures compared
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Endothelial Cells Rescue Irradiated Stem Cells
Bith cultures with TSF alone (P  .01). Figure 2
hows a representative phenotypic analysis of day 0
M and CB CD34 cells after 400 cGy of irradiation
nd their progeny after culture with TSF alone and
UBEC contact and noncontact cultures.
oculture with HUBECs Supports the Recovery of
olony-Forming Cells from Irradiated BM and CB
Colony-forming cell (CFC) assay of normal and
00 cGy–irradiated day 0 BM and CB CD34 cells
ighlighted the ablative effects of 400 cGy of ionizing
adiation on hematopoietic progenitor cell activity (Fig-
re 3). The 400 cGy–irradiated BM CD34 cells con-
ained 18.4-fold less CFC content (CFU-total; P .001)
nd showed marked reductions in BFU-E (6.9-fold re-
uction) and CFU-GM (32.7-fold reduction) content
nd a complete loss of CFU-Mix colonies, as compared
ith nonirradiated BM CD34 cells. Signiﬁcant re-
uctions in CFU-total (P  .008; Figure 3), BFU-E,
FU-GM, and CFU-Mix content were also observed
fter irradiation of CB CD34 cells.
Both contact and noncontact HUBEC cultures
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igure 1. HUBEC culture supports the recovery of irradiated hum
rradiated in vitro with 400 cGy and placed in culture with TSF a
ulture. The mean recovery of total cells (A) and CD34CD38 cel
f both populations via coculture with HUBECs under contact and n
f total cells (C) and CD34CD38 cells (D) within 400 cGy–irrad
oncontact HUBEC culture as compared with TSF alone. *The me
hat in the TSF culture group.upported the recovery of CFCs from 400 cGy–irra- n
B&MTiated BM CD34 cells at levels signiﬁcantly greater
han TSF alone (3.6-fold and 3.9-fold increased CFU-
otal, respectively; P  .001 and P  .002). HUBEC
ontact and noncontact cultures also recovered
FU-E and CFU-Mix colonies, which were com-
letely absent from TSF-cultured progeny of irradi-
ted BM CD34 cells (data not shown). HUBEC
ontact and noncontact cultures of 400 cGy–irradiated
B CD34 cells yielded similar results, with signiﬁ-
ant increases in CFU-total content (3.2-fold and 3.0-
old; P  .02 and P  .005, respectively), as well as
FU-E, CFU-GM, and CFU-Mix (data not shown),
s compared with TSF alone (Figure 3).
oculture with HUBECs Reduces Hematopoietic
rogenitor Cell Death after Radiation Exposure
We hypothesized that ECs might elaborate anti-
poptotic factors that could promote the recovery of
ematopoietic progenitor cells after radiation injury.
nalysis with Annexin V and 7-AAD revealed inter-
sting similarities and differences in the percentage of
poptotic (Annexin V/7-AAD) and necrotic (An-
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5D34 cells, the irradiated BM CD34 cells, and the
rogeny of irradiated BM CD34 cells under different
ulture conditions. Notably, overall cell death was
igniﬁcantly increased within 400 cGy–irradiated BM
D34 cells measured 6 hours after irradiation as
ompared with nonirradiated BM CD34 cells (Fig-
re 4). Analysis of the entire population of irradiated
M cells demonstrated moderately increased apopto-
is and necrosis in TSF cultures as compared with
oth HUBEC contact and noncontact cultures, and
his was most evident at day 3 and day 10 (Figure 4A).
ithin the CD34 progenitor cell subset, TSF cul-
ure was associated with a signiﬁcant increase in cell
eath over time as compared with both HUBEC con-
act and noncontact cultures (Figure 4B).
UBEC Culture Supports the Recovery of
epopulating Stem Cells from Irradiated Human
M CD34 Cells
NOD/SCID mice received transplants via tail vein
njection with day 0 normal (nonirradiated), day 0 400
Gy–irradiated, or the progeny of 400 cGy–irradiated
M CD34 cells after a 10-day culture with HUBECs
r TSF alone. We observed that exposure to 400 cGy
f ionizing radiation had a profoundly deleterious
ffect on the repopulating capacity of BM CD34
igure 2. HUBEC coculture maintains a higher percentage of
Gy–irradiated BM and CB CD34 cells were placed in 10-day cul
epresentative analysis of day 0 400 cGy–irradiated BM CD34 cell
evealing a nearly complete loss of CD34CD38 cells (Aii). In
aintained a population of CD34CD38 cells at day 10. Similar
uring HUBEC contact and noncontact cultures (B). The percenta
ITC indicates ﬂuorescein isothiocyanate.ells. Mice that underwent transplantation with a dose a
34f 0.75  106 nonirradiated BM CD34 cells demon-
trated low-level (mean, 0.1% human CD45 cells)
ngraftment in 50% of transplanted animals (Figure 5).
onversely, mice that underwent transplantation with
ay 0 400 cGy–irradiated BM CD34 cells or their
ay 10 progeny after culture with TSF alone demon-
trated no human cell engraftment. Mice that under-
ent transplantation with the progeny of 0.75  106
00 cGy–irradiated BM CD34 cells after HUBEC
ontact culture also showed no human CD45 cell
ngraftment 0.1%, although a single mouse had
.02% human CD45 cells at 8 weeks after trans-
lantation.
At a dose of 1.5  106 nonirradiated BM CD34
ells, 100% of transplanted mice demonstrated human
D45 cell engraftment at high levels (mean, 36.8%
uman CD45 cells). Conversely, mice that under-
ent transplantation with 400 cGy–irradiated BM
D34 cells showed human CD45 cell engraftment in
5% of animals, with signiﬁcantly lower levels of en-
raftment (mean, 1.0% human CD45 cells; Figure 5).
his indicates that a small population of SRCs was
ble to survive 400 cGy of radiation injury. It is inter-
sting to note that the progeny of the identical dose of
00 cGy–irradiated BM CD34 cells cultured with
SF alone for 10 days were incapable of engrafting
CD38 cells after radiation injury than TSF alone. The 400
d analyzed by ﬂow cytometry to determine phenotype changes. A
wn (Ai), along with analysis of the day 10 progeny of TSF culture,
t, HUBEC contact (Aiii) and HUBEC noncontact (Aiv) cultures
nance of CB CD34CD38 cells after 400 cGy was also observed
cells in each quadrant are shown in the upper right of each ﬁgure.CD34
tures an
s is sho
contras
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ges ofnd repopulating any transplanted mice; this suggests
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Endothelial Cells Rescue Irradiated Stem Cells
Bhat cytokine treatment was insufﬁcient and possibly
eleterious toward the survival of primitive long-term
epopulating stem cells after high-dose radiation ex-
osure. In contrast, the progeny of 1.5  106 400
Gy–irradiated BM CD34 cells cultured under non-
ontact conditions with HUBECs engrafted in 100%
f transplanted mice with a mean engraftment level of
.5% human CD45 cells per mouse, thus demon-
trating that soluble endothelial factors promoted the
ecovery of irradiated human HSCs independently of
ell-cell contact.
Representative phenotypic analyses of human
D45 cell frequencies in mice that underwent trans-
lantation with nonirradiated BM CD34 cells, irra-
iated BM CD34 cells, and the progeny of 400
Gy–irradiated BM CD34 cells after culture with
SF alone versus noncontact HUBEC culture are
hown in Figure 6A. Of note, mice that underwent
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igure 3. HUBEC contact and noncontact cultures promote the
ecovery of CFCs compared with TSF alone. Day 0 normal and 400
Gy–irradiated CD34 cells and the day 10 progeny of 400 cGy–
rradiated CD34 cells after culture with TSF alone, HUBEC
ontact, and HUBEC noncontact culture were analyzed for CFC
ontent after 14 days. The 400-cGy exposure caused a signiﬁcant
eduction in human CFC content at day 0. The progeny of 400
Gy–irradiated BM CD34 cells (A) and CB CD34 cells (B) after
UBEC contact and noncontact cultures contained signiﬁcantly
ore CFU-total as compared with the progeny of 400 cGy–irradi-
ted CD34 cells cultured with TSF alone. *The mean number of
ells in the identiﬁed condition is signiﬁcantly different from that in
he TSF culture group. D indicates day.ransplantation with the progeny of 400 cGy–irradi- [
B&MTted BM CD34 cells cultured with HUBECs under
oncontact conditions demonstrated multilineage (B
ymphoid and myeloid) engraftment, thus indicating
hat multipotent stem/progenitor cells were main-
ained after irradiation and HUBEC coculture (Fig-
re 6B). Of note, the proportion of B lymphoid re-
eneration in mice that underwent transplantation
ith irradiated/HUBEC-cultured cells was compara-
ively higher than the observed regeneration of
D13 myeloid progeny, and this suggests a poten-
ially important difference with regard to the native
ecovery of B lymphoid progenitors versus myeloid
rogenitors after high-dose irradiation.
ISCUSSION
Recently, because of the acknowledged risk of
uclear or radiological terrorism over the coming de-
ade, there has been renewed interest in the develop-
ent of medical countermeasures to the effects of
onizing radiation exposure [1-4]. Therapies directed
t ameliorating the hematologic toxicity of ionizing
adiation would be of particular interest because BM
ailure is the leading cause of death in victims of pure
onizing radiation injury [1-4,34,35]. In animal mod-
ls, administration of cytokines such as SCF, MGDF,
lt-3 ligand, IL-1, or tumor necrosis factor  before
r immediately at the time of high-dose total body
adiation exposure can provide radioprotection and
mprove survival [8-12,16-18]. Similarly, the com-
ined administration of multiple cytokines, including
CF, Flt-3 ligand, MGDF, IL-3, and SDF-1, within 2
ours after sublethal and near-lethal irradiation has
een associated with decreased myelosuppression and
mproved survival in mice and baboons [13,36]. How-
ver, in the event of a radiologic or nuclear catastro-
he, the administration of hematopoietic cytokines
ill not be feasible for many within the ﬁrst 2 hours of
xposure, and it is unclear whether the administration
f cytokines more than a few hours after exposure
ould be therapeutically valuable after higher-dose
xposures. SCF, for example, has no effect on radia-
ion-induced myelosuppression and mortality when
dministered only 4 hours after high-dose radiation
xposure [9], and granulocyte colony-stimulating fac-
or, which clearly accelerates myeloid recovery in pri-
ates after sublethal exposures [37-40], has no effect
hen administered to mice after an exposure of 10.5
y [40]. Although we did not measure the capacity for
UBEC coculture to rescue human HSCs irradiated
n vitro with doses 400 cGy, we have recently dem-
nstrated that fully functional BM stem and progen-
tor cells can be rescued after harvest from lethally
rradiated (1050 cGy of total body irradiation)
57BL/6 mice via coculture with porcine brain ECs19]. Because few studies have been performed to
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536haracterize the regenerative capacity of human HSCs
fter ionizing radiation exposure, we propose that the
UBEC coculture model has the potential to yield
mportant insights regarding EC-derived factors that
ay be radioprotective.
In this study, we showed that primary human BM
D34 cells are exquisitely sensitive to 400 cGy of
xposure in vitro, thus resulting in dramatic declines
n CFC and SRC content after injury. Treatment with
ematopoietic cytokines alone was associated with an
ncrease in apoptosis and necrosis of irradiated BM
D34 cells and a marked decline in CD34CD38
ells and SRCs compared with input, despite treat-
ent within 4 hours of exposure, thus suggesting that
ytokine treatment of human BM HSCs after high-
ose irradiation may, in fact, be deleterious to their
ecovery. These results are in contrast to the obser-
ations of Drouet et al. [27], who reported that early
reatment of baboon BM CD34 cells with SCF, Flt-3
igand, thrombopoietin, and IL-3 decreased Fas ligand–
ediated apoptosis in vitro. However, in that study, the
uthors did not examine the long-term repopulating
otential of the irradiated baboon cells after cytokine
reatment, so conclusions regarding the effect of cy-
okines on baboon HSCs cannot be drawn [27]. In
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igure 4. HUBEC coculture decreases hematopoietic progenitor cell dea
urity) were irradiated with 400 cGy and subsequently placed in cultur
upplemented with TSF. Flow cytometric analysis was performed to m
ondition over time. Day 0 nonirradiated BM CD34 cells and 400 c
nalysis of the entire population demonstrated that 400 cGy caused a si
fter exposure (P  .05 for each comparison). By days 3 and 10, a mo
ecrotic cells was observed within HUBEC contact and noncontact cul
D34 progenitor cell subset over time demonstrated a more signiﬁ
oncontact cultures as compared with TSF alone (P  .05 for each com
ulture on progenitor cell repair after radiation injury. *The mean perce0.01
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iated or 400 cGy–irradiated BM CD34 cells per mouse or the
rogeny of 400 cGy–irradiated BM CD34 cells after culture
ith TSF alone or HUBEC contact (open circles) and noncon-
act (ﬁlled circles) cultures. The dose of 400 cGy caused a marked
eduction in day 0 SRC content, and culture of 400 cGy–irradi-
ted BM CD34 cells with TSF alone was associated with a
omplete loss of SRC over time. Conversely, noncontact culture
ith HUBECs maintained SRC content, thus indicating that
oluble factors produced by HUBECs contributed to HSC re-ddition, ionizing radiation induces mammalian cells,
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Bigure 6.Noncontact culture of 400 cGy–irradiated BM CD34 cells with HUBECs maintains cells with multilineage differentiative capacity.
, Representative NOD/SCID BM analysis is shown from mice injected with 1.5  106 nonirradiated BM CD34 cells (Ai), 400
Gy–irradiated day 0 BM CD34 cells (Aii), or the progeny of the identical dose of 400 cGy–irradiated BM CD34 cells after a 10-day culture
ith TSF alone (Aiii) or HUBEC noncontact culture (Aiv). B, Multiparameter ﬂow cytometric analysis was performed on engrafted human
ells in representative mice. Isotype control staining is shown (Bi), and CD34 progenitor cells were demonstrated (Bii), as were CD19 B
ells (Biii) and CD13 myeloid cells (Biv) in transplanted mice at 8 weeks. The relative proportion of B cells in the transplanted mice was
ncreased as compared with myeloid cells; this indicates that lymphoid recovery may have occurred more rapidly after radiation injury. FITC
ndicates ﬂuorescein isothiocyanate; PerCP, peridinin-chlorophyll protein complex.
537B&MT
i
p
C
i
r
[
p
i
t
[
C
a
C
e
t
c
e
C
c
c
t
H
c
t
c
p
S
o
b
a
w
m
w
t
e
E
f
a
t
s
t
r
t
S
c
c
w
g
r
o
c
[
t
c
b
t
W
H
t
m
W
t
o
d
p
l
v
a
H
s
N
b
o
i
i
a
p
t
a
p
a
c
t
r
c
m
h
(
s
a
l
o
e
t
a
r
t
a
s
s
o
c
t
i
R
G. G. Muramoto et al.
5n general, to undergo either cell-cycle arrest or apo-
tosis in the immediate postexposure period [41,42].
ells that undergo p53-independent cell-cycle arrest
n G1 or G2/M phase have the potential to repair
adiation-induced DNA damage and avoid cell death
43]. Because the cytokine combination of thrombo-
oietin, SCF, and Flt-3 ligand has been shown to
nduce nearly 100% of human CB CD34 cells
hrough at least 1 cell division by 1 week of culture
33], it is plausible that exposure of irradiated BM
D34 cells to these proliferation-inducing cytokines
ccelerates the demise of stem and progenitor cells.
onversely, HUBEC contact cultures and, to a lesser
xtent, HUBEC noncontact cultures decreased radia-
ion-induced apoptosis and necrosis of BM CD34
ells and promoted a signiﬁcant increase in the recov-
ry of total viable cells, CD34CD38 cells, and
FCs as compared with TSF alone. These results are
onsistent with prior studies that suggested that that
ell-cell contact interactions (eg, Jagged-Notch) be-
ween HSCs and other stromal cell types are critical to
SC survival [22,23,44].
It is interesting to note that although HUBEC
ontact cultures supported a greater recovery of
otal viable cells and CD34CD38 cells than non-
ontact cultures, HUBEC noncontact cultures sup-
orted a potent recovery of the most primitive
RCs. These data can be potentially explained, as
thers have shown [31], by the lack of correlation
etween stem cell content and phenotypic indicators
fter ex vivo culture. It is also possible that coculture
ith HUBECs induced cell-cycle arrest in HSCs as a
echanism of radioprotection, as has been described
hen murine embryonic neural stem cells were cul-
ured in contact with murine brain ECs [45]. How-
ver, we have found that coculture with porcine brain
Cs induces the proliferation of BM HSCs harvested
rom lethally irradiated mice [19], thus suggesting that
true expansion of radioprotected HSCs occurs via
his strategy.
It is important to note that our results demon-
trate that soluble factors produced by ECs support
he survival and regeneration of human HSCs after
adiation injury. Our previous analyses have shown
hat established hematopoietic cytokines, including
CF, Flt-3 ligand, thrombopoietin, granulocyte
olony-stimulating factor, granulocyte-macrophage
olony-stimulating factor, and IL-3, are not enriched
ithin HUBEC conditioned media [46]. This sug-
ests that potentially novel prosurvival factors elabo-
ated by HUBECs account for the effects we have
bserved. This soluble activity may be unique to vas-
ular ECs as well. Recent studies by Mourcin et al.
47] and Drouet et al. [48] demonstrated that cocul-
ure with mesenchymal stem cells supported the re-
overy of 400 cGy–irradiated baboon CD34 cells,
ut this was dependent on cell-cell contact between
38he irradiated cells and the mesenchymal stem cells.
e are currently pursuing identiﬁcation of the
UBEC-soluble proteins that are responsible for
he observed radiotherapeutic effects, via comple-
entary genomic and protein fractionation strategies.
e anticipate that the identiﬁcation and characteriza-
ion of these soluble proteins may facilitate the devel-
pment of therapeutics to counteract radiation-in-
uced myelosuppression.
The results presented here suggest that hemato-
oietic progenitor cells could, in principle, be col-
ected from radiation-accident victims, expanded ex
ivo, and transplanted in an autologous manner to
ccelerate the hematopoietic recovery of such victims.
owever, in the event of a mass casualty situation,
uch an approach would not be logistically feasible.
onetheless, these data suggest an important contri-
ution of vascular ECs to the repair and regeneration
f human BM stem and progenitor cells after radiation
njury. In other disease models, such as myocardial
nfarction and peripheral vascular disease, the anti-
poptotic activity of circulating ECs has been pro-
osed [49]. In addition, Kopp et al. [50] have shown
he potential contribution of the BM vascular niche
nd angiogenic factors toward accelerating hemato-
oietic recovery after myelosuppressive chemother-
py. Targeted therapies aimed at accelerating the re-
overy of the BM vascular endothelial niche may
herefore be of beneﬁt in the treatment of victims of
adiation injury. As proof of principle, we have re-
ently observed that tail vein transplantation of pri-
ary vascular ECs is radioprotective and accelerates
ematopoietic recovery in lethally irradiated mice
Chute J, unpublished data).
A recent workshop on radiation countermea-
ures sponsored by the National Institute of Allergy
nd Infectious Diseases concluded that the current
ack of effective therapeutic agents for the treatment
f radiation victims is a major problem in the gov-
rnment’s preparation for radiologic or nuclear ca-
astrophes [1]. More broadly, newly developed ther-
pies that accelerate hematopoietic recovery after
adiation injury could also have application in at-
enuating the myelotoxic effects of chemotherapy
nd radiotherapy in patients with cancer. Our re-
ults indicate that human vascular ECs elaborate
oluble factors that support the repair and recovery
f irradiated human stem and progenitor cells. The
haracterization of these novel factors has the po-
ential to lead to targeted therapies for radiation-
nduced myelosuppression.
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